KRAS c.100C>T ;(p.P34S)

Variant ID: 12-25398219-G-A

NM_004985.3(KRAS):c.100C>T;(p.P34S)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use.

International Journal Of Molecular Medicine
Chevrier, Sandy S; Brasselet, Astrid A; Carnet, Marion M; Chevriaux, Angélique A; Gibeaud, Anne A; Jourdain, Marine M; Mananet, Hugo H; Truntzer, Caroline C; Beltjens, Françoise F; Charon-Barra, Céline C; Arnould, Laurent L; Albuisson, Juliette J; Comte, Anthony A; Derangère, Valentin V; Goussot, Vincent V; Boidot, Romain R
Publication Date: 2022-05

Variant appearance in text: KRAS: 100C>T; Pro34Ser
PubMed Link: 35244186
Variant Present in the following documents:
  • Supplementary_Data2.xlsx, sheet 1
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: KRAS: P34S
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 2
  • pone.0196434.s001.xlsx, sheet 3
  • pone.0196434.s001.xlsx, sheet 1
View BVdb publication page



Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report.

Bmc Pulmonary Medicine
Dong, Liang L; Xia, Jingwen J; Zhang, Jing J; Zhang, Yuanyuan Y; Zhu, Ning N; Zhang, Peng P; Zhang, Youzhi Y; Zhang, Xiujuan X; Li, Shengqing S
Publication Date: 2018-01-23

Variant appearance in text: KRAS: P34S
PubMed Link: 29361925
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers.

Oncotarget
Lee, Boram B; Lee, Taebum T; Lee, Se-Hoon SH; Choi, Yoon La YL; Han, Joungho J
Publication Date: 2016-04-26

Variant appearance in text: KRAS: P34S
PubMed Link: 26992209
Variant Present in the following documents:
  • Main text
  • oncotarget-07-23874.pdf
  • oncotarget-07-23874-s001.pdf
View BVdb publication page



Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.

Molecular Systems Biology
Kiel, Christina C; Serrano, Luis L
Publication Date: 2014-05-06

Variant appearance in text: KRAS: P34S
PubMed Link: 24803665
Variant Present in the following documents:
  • MSB-10-5-727-s13.xls, sheet 1
View BVdb publication page



Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research
Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C
Publication Date: 2011-09-01

Variant appearance in text: KRAS: P34S
PubMed Link: 21727090
Variant Present in the following documents:
  • supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1
View BVdb publication page



Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.

Molecular Cancer
Do, Hongdo H; Dobrovic, Alexander A
Publication Date: 2009-10-08

Variant appearance in text: KRAS: 100C>T
PubMed Link: 19811662
Variant Present in the following documents:
  • Main text
  • 1476-4598-8-82.pdf
View BVdb publication page